Back
Apellis Pharmaceuticals Vs. Transcat Industry Stock Comparison
Sell
22
APLS
Apellis Pharmaceuticals
Last Price:
$17.44
Seasonality Move:
-14.59%
Sell
47
TRNS
Transcat
Last Price:
$84.83
Seasonality Move:
4.09%
Sell
22
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
-
The current Apellis Pharmaceuticals [APLS] share price is $17.43. The Score for APLS is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
-
APLS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
Transcat (TRNS)
is a Sell
Is Transcat a Buy, Sell or Hold?
-
TRNS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $17.43Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing selling pressure, which indicates risk of future bearish movement.
TRNS Stock Price Chart
APLS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.13 | Sell |
Relative Strength Index (14 RSI): | 41.91 | Sell |
Chaikin Money Flow: | -3543940 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (17.42 - 19.1) | Sell |
Bollinger Bands (100): | (17.42 - 25.66) | Sell |
TRNS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.15 | Buy |
Relative Strength Index (14 RSI): | 56.81 | Buy |
Chaikin Money Flow: | -82899 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (77.86 - 87.82) | Buy |
Bollinger Bands (100): | (74.31 - 84.93) | Buy |
APLS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 17.96 | Sell |
20-day SMA: | 18.5 | Sell |
50-day SMA: | 18.15 | Sell |
200-day SMA: | 26.32 | Sell |
8-day EMA: | 18.1 | Sell |
20-day EMA: | 18.25 | Sell |
50-day EMA: | 19.02 | Sell |
200-day EMA: | 26.54 | Sell |
TRNS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 82.14 | Buy |
20-day SMA: | 80.91 | Buy |
50-day SMA: | 82.5 | Buy |
200-day SMA: | 95.34 | Sell |
8-day EMA: | 82.57 | Buy |
20-day EMA: | 81.92 | Buy |
50-day EMA: | 81.95 | Buy |
200-day EMA: | 91.41 | Sell |
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.19 per share, a decrease this year of $0.13 per share, and an increase next year of $1.13 per share.
Transcat Earnings Growth & TRNS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.11 per share, a decrease this year of $0.33 per share, and a decrease next year of $0.11 per share.
Apellis Pharmaceuticals Technical Analysis
Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
13 | 16 | 17 | 18 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Transcat Technical Analysis
Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
13 | 16 | 17 | 18 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |